Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

Logistics companies globally are leaning into emerging technologies such as robots, drones and AI to speed up the supply chain and serve customers faster.

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Novo Nordisk is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical ...

Also, Novo Nordisk offers the possibility of viewing the Annual General Meeting via live webcast on Novo Nordisk's website. Please refer to the enclosed notice for the Annual General Meeting for ...

Ricks noted that there is a "real gap in supply chain in the U.S. as it relates ... the booming market for so-called GLP-1 drugs with Novo Nordisk's weight loss drug Wegovy and diabetes treatment ...

Eli Lilly CEO Dave Ricks says that even with both Eli Lilly and Novo Nordisk ... supply by either of those two companies. Most APIs are made in outside of the United States, which has gained attention ...

In a statement, Novo Nordisk Executive Vice President of U.S. Operations and Global Business Development Dave Moore said, “We are pleased the FDA has declared that supply of the only real ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood ...

AS Heart Month reminds us of the critical need to protect our cardiovascular and metabolic health, Novo Nordisk Philippines and the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM) ...